Driven by Our Passion to Generate Advances in Drug Discovery
For more than 35 years, our scientific insights and bold ambitions for transforming the course of disease have guided Gilead researchers to achieve advancements in drug discovery that were once thought impossible – including cures. We aim to continuously bring new therapies into clinical development and are propelled by our passion to save the lives of millions of people around the world.
Our R&D ApproachWe’re on a mission to generate transformative medicines for people living with viral diseases, cancer and inflammatory conditions.
Explore Therapeutic AreasClinical Programs in Development
R&D Investment in 2023
Total Employees Globally
Research Funding Programs
We actively support innovative research that addresses critical patient needs. Gilead offers a number of opportunities to advance studies that align with our mission.
View Research Funding ProgramsLatest Research Publications
Some of the content on this page is not intended for users outside the U.S.
Clinical Trials
We're committed to involving the communities most impacted by disease in the design and execution of our clinical trials.
Medicines
We currently offer more than 25 therapies in the United States and are rapidly growing our portfolio through internal research and development and external collaborations.
Gilead's
Research Sites
With a network of state-of-the-art R&D facilities, Gilead continually pushes the boundaries of scientific discovery and drug development.
Grow With Us
With more than 18,000 employees spanning across 35+ countries on six continents, Gilead has a global workforce dedicated to creating a better, healthier world for everyone.
Explore Opportunities